News

Selected as a Supported Company under the FY2026 Intensive Support Program for Next-Generation Medical Device Development and Commercialization

News ReleaseOSferionBiomaterials Corp.

On October 27, 2025, OSferionBiomaterials Corp., a member of our group, was selected as a supported company under the “FY2026 Intensive Support Program for Next-Generation Medical Device Development and Commercialization,” administered by the Fujinokuni Medical Town Promotion Organization.
This program aims to revitalize Shizuoka Prefecture’s medical and healthcare industry by creating model cases of advanced medical device development by highly skilled local companies and fostering a positive cycle that encourages the entry of other outstanding businesses.
Leveraging this support, our company will continue to contribute to the development of high-performance medical devices and the growth of the medical and healthcare industry.